Search research articles
Contact Us
Filters
Showing results (371-380 of 419) with videos related to
Page
of 42
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
May 10, 2025
Real-world outcomes of subsequent treatment strategies after durvalumab consolidation in stage III unresectable non-small cell lung cancer
Veronica Crespi, Marco Donatello Delcuratolo, Gabriele Minuti, et al.
Open Forum Infectious Diseases
|
May 29, 2020
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing <i>Enterobacterales</i> Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study)
Matteo Bassetti, Antonio Vena, Daniele Roberto Giacobbe, et al.
Journal of Extracellular Vesicles
|
November 19, 2024
Extracellular vesicles containing SARS-CoV-2 proteins are associated with multi-organ dysfunction and worse outcomes in patients with severe COVID-19
Diego de Miguel-Perez, Marisol Arroyo-Hernandez, Sabrina La Salvia, et al.
Translational Oncology
|
November 25, 2021
p.G12C KRAS mutation prevalence in non-small cell lung cancer: Contribution from interregional variability and population substructures among Hispanics
Alejandro Ruiz-Patiño, July Rodríguez, Andrés F Cardona, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 1, 2022
Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer
Diego de Miguel-Perez, Alessandro Russo, Oscar Arrieta, et al.
Journal of Medical Virology
|
May 28, 2024
Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients
Grazia Pavia, Angela Quirino, Nadia Marascio, et al.
The Journal of Antimicrobial Chemotherapy
|
February 25, 2025
Clinical characteristics, therapy and outcome of bloodstream infections caused by vancomycin-resistant enterococci: a multicentre clinical experience
Francesca Serapide, Riccardo Serraino, Luigi Spadafora, et al.
Frontiers in Oncology
|
March 4, 2026
Real-world description of patients with resected epidermal growth factor receptor mutation positive non-small cell lung carcinoma treated with adjuvant osimertinib in an early access program in Italy: the ELBA observational study
Giulia Pasello, Claudia Proto, Carlo Genova, et al.
Eclinicalmedicine
|
May 6, 2026
Managing <i>Enterococcus faecium</i> bloodstream infection: a Delphi document on clinical recommendations and research agenda
Matteo Rinaldi, Michele Bartoletti, Piergiorgio Cojutti, et al.
Advances in Therapy
|
February 1, 2020
Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study
Alessandro Russo, Marco Russano, Tindara Franchina, et al.
Page
of 42
Search research articles
Search
Showing results (371-380 of 419) with videos related to
Sort By:
Page
of 42
Lung Cancer (Amsterdam, Netherlands)
|
May 10, 2025
Real-world outcomes of subsequent treatment strategies after durvalumab consolidation in stage III unresectable non-small cell lung cancer
Veronica Crespi, Marco Donatello Delcuratolo, Gabriele Minuti, et al.
Open Forum Infectious Diseases
|
May 29, 2020
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing <i>Enterobacterales</i> Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study)
Matteo Bassetti, Antonio Vena, Daniele Roberto Giacobbe, et al.
Journal of Extracellular Vesicles
|
November 19, 2024
Extracellular vesicles containing SARS-CoV-2 proteins are associated with multi-organ dysfunction and worse outcomes in patients with severe COVID-19
Diego de Miguel-Perez, Marisol Arroyo-Hernandez, Sabrina La Salvia, et al.
Translational Oncology
|
November 25, 2021
p.G12C KRAS mutation prevalence in non-small cell lung cancer: Contribution from interregional variability and population substructures among Hispanics
Alejandro Ruiz-Patiño, July Rodríguez, Andrés F Cardona, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 1, 2022
Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer
Diego de Miguel-Perez, Alessandro Russo, Oscar Arrieta, et al.
Journal of Medical Virology
|
May 28, 2024
Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients
Grazia Pavia, Angela Quirino, Nadia Marascio, et al.
The Journal of Antimicrobial Chemotherapy
|
February 25, 2025
Clinical characteristics, therapy and outcome of bloodstream infections caused by vancomycin-resistant enterococci: a multicentre clinical experience
Francesca Serapide, Riccardo Serraino, Luigi Spadafora, et al.
Frontiers in Oncology
|
March 4, 2026
Real-world description of patients with resected epidermal growth factor receptor mutation positive non-small cell lung carcinoma treated with adjuvant osimertinib in an early access program in Italy: the ELBA observational study
Giulia Pasello, Claudia Proto, Carlo Genova, et al.
Eclinicalmedicine
|
May 6, 2026
Managing <i>Enterococcus faecium</i> bloodstream infection: a Delphi document on clinical recommendations and research agenda
Matteo Rinaldi, Michele Bartoletti, Piergiorgio Cojutti, et al.
Advances in Therapy
|
February 1, 2020
Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study
Alessandro Russo, Marco Russano, Tindara Franchina, et al.
Page
of 42